Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2017 (2017), Article ID 7680434, 8 pages
https://doi.org/10.1155/2017/7680434
Research Article

Polymorphism rs2073618 of the TNFRSF11B (OPG) Gene and Bone Mineral Density in Mexican Women with Rheumatoid Arthritis

1Unidad Biomédica 02, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades, Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), 44340 Guadalajara, JAL, Mexico
2Doctorado en Farmacología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara (U. de G.), 44340 Guadalajara, JAL, Mexico
3División de Ciencias de la Salud, Departamento de Ciencias Biomédicas, Centro Universitario de Tonalá (CUTonalá), U. de G., 48525 Tonalá, JAL, Mexico
4Instituto de Investigación en Reumatología y del Sistema Músculo Esquelético, CUCS, U. de G., 44340 Guadalajara, JAL, Mexico
5UDG-CA-703, Grupo de Investigación en Inmunología y Reumatología, CUCS, U. de G., 44340 Guadalajara, JAL, Mexico
6Departamento de Biología Molecular y Genómica, CUCS, U. de G., 44340 Guadalajara, JAL, Mexico
7División de Investigación, UMAE, Hospital de Especialidades, CMNO, IMSS, 44349 Guadalajara, JAL, Mexico
8Departamento de Farmacobiología, Centro Universitario de Ciencias Exactas e Ingeniería (CUCEI), U. de G., 44430 Guadalajara, JAL, Mexico
9Departamento de Epidemiología, Unidad Médica Familiar 4 y 8, IMSS, 44220 Guadalajara, JAL, Mexico
10Departamento de Salud Pública, CUCS, U. de G., 44340 Guadalajara, JAL, Mexico
11Departamento de Medicina Interna-Reumatología, Hospital General Regional 110, IMSS, 44710 Guadalajara, JAL, Mexico
12División de Ciencias de la salud, Departamento Salud-Enfermedad como Proceso Individual, CUTonalá, U. de G., 48525 Tonalá, JAL, Mexico
13UDG CA-701 Grupo de Investigación Inmunometabolismo en Enfermedades Emergentes (GIIEE), CUCS, U. de G., 44340 Guadalajara, JAL, Mexico
14Laboratorio de Investigación y Desarrollo Farmacéutico, CUCEI, U. de G., 44430 Guadalajara, JAL, Mexico
15Unidad Medica Familiar 97, IMSS, 46470 Magdalena, JAL, Mexico
16Programa de Doctorado en Ciencias Médicas, Universidad de Colima, 28040 Colima, COL, Mexico
17Departamento de Medicina Interna-Reumatología, Hospital General de Zona 45, IMSS, 44860 Guadalajara, JAL, Mexico

Correspondence should be addressed to J. I. Gamez-Nava; xm.ten.ygidorp@zemagnavird

Received 4 January 2017; Revised 6 May 2017; Accepted 18 May 2017; Published 5 July 2017

Academic Editor: Fulvia Ceccarelli

Copyright © 2017 C. A. Nava-Valdivia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Singh, K. G. Saag, S. L. Bridges Jr. et al., “2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis,” Arthritis and Rheumatology, vol. 68, no. 1, pp. 1–26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. M. F. Alcaraz-Lopez, L. Gonzalez-Lopez, L. Aguilar-Chavez, M. A. Lopez-Olivo, C. Loaiza-Cardenas, and J. I. Gamez-Nava, “Performance of albrand index for identifying low bone density in rheumatoid arthritis,” Journal of Rheumatology, vol. 33, no. 2, pp. 408-409, 2006. View at Google Scholar
  3. K. Arai, T. Hanyu, H. Sugitani et al., “Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study,” Journal of Bone and Mineral Metabolism, vol. 24, no. 2, pp. 118–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Mohammad, D. Lohan, D. Bergin et al., “The prevalence of vertebral fracture on vertebral fracture assessment imaging in a large cohort of patients with rheumatoid arthritis,” Rheumatology, vol. 53, no. 5, pp. 821–827, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Ishida, T. Furuya, E. Inoue et al., “Risk factors for established vertebral fractures in Japanese patients with rheumatoid arthritis: results from a large prospective observational cohort study,” Modern Rheumatology, vol. 25, no. 3, pp. 373–378, 2015. View at Google Scholar
  6. G. Haugeberg, T. Uhlig, J. A. Falch, J. I. Halse, and T. K. Kvien, “Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo county rheumatoid arthritis register,” Arthritis and Rheumatism, vol. 43, no. 3, pp. 522–530, 2000. View at Publisher · View at Google Scholar
  7. W. S. Simonet, D. L. Lacey, C. R. Dunstan et al., “Osteoprotegerin: a novel secreted protein involved in the regulation of bone density,” Cell, vol. 89, no. 2, pp. 309–319, 1997. View at Publisher · View at Google Scholar
  8. T. Wada, T. Nakashima, N. Hiroshi, and J. M. Penninger, “RANKL–RANK signaling in osteoclastogenesis and bone disease,” Trends in Molecular Medicine, vol. 12, no. 1, pp. 17–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. B. F. Boyce and L. Xing, “Functions of RANKL/RANK/OPG in bone modeling and remodeling,” Archives of Biochemistry and Biophysics, vol. 473, no. 2, pp. 139–146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Teitelbaum, “Bone resorption by osteoclasts,” Science, vol. 289, no. 5484, pp. 1504–1508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Morinaga, N. Nakagawa, H. Yasuda, E. Tsuda, and K. Higashio, “Cloning and characterization of gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor,” European Journal of Biochemistry, vol. 254, no. 3, pp. 685–691, 1998. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Zhao, J. Liu, G. Ning et al., “The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women,” Osteoporosis International, vol. 16, no. 12, pp. 1519–1524, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Wynne, F. Drummond, K. O’Sullivan et al., “Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population,” Calcified Tissue International, vol. 71, no. 1, pp. 26–35, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Arko, J. Prezelj, A. Kocijancic, R. Komel, and J. Marc, “Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women,” Maturitas, vol. 51, no. 3, pp. 270–279, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. B. L. Langdahl, M. Carstens, L. Stenkjaer, and E. F. Eriksen, “Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures,” Journal of Bone and Mineral Research, vol. 17, no. 7, pp. 1245–1255, 2002. View at Publisher · View at Google Scholar
  16. C. Sánchez-Serrano, Mestizaje e historia de la población en México, Real Academia de Ciencias Exactas Físicas y Naturales, Madrid, España, 1996.
  17. S. A. Miller, D. D. Dykes, and H. F. Polesky, “A simple salting out procedure for extracting DNA from human nucleated cells,” Nucleic Acids Research, vol. 16, no. 3, p. 1215, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Y. Choi, A. Shing, S. K. Park et al., “Genetic polymorphisms of OPG, RANK, and ESR1, and bone mineral density in Korean postmenopausal women,” Calcified Tissue International, vol. 77, no. 3, pp. 152–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. M. T. García-Unzueta, J. A. Riancho, M. T. Zarrabeitia et al., “Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density,” Hormone and Metabolic Research, vol. 40, no. 3, pp. 219–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. J. G. Kim, J. H. Kim, J. Y. Kim et al., “Association between osteoprotegerin (OPG), receptor activator of nuclear factor-JB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women,” Menopause, vol. 14, no. 5, pp. 913–918, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. S. P. Moffett, J. I. Oakley, J. A. Cauley et al., “Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 5, pp. 2002–2008, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. H. Lee, J. Woo, S. J. Choi, J. D. Ji, and G. G. Song, “Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis,” Molecular Biology Reports, vol. 37, no. 1, pp. 227–234, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. L. Guo, K. Tang, Z. Quan, Z. Zhao, and D. Jiang, “Association between seven common OPG genetic polymorphisms and osteoporosis risk: a meta-analysis,” DNA and Cell Biology, vol. 33, no. 1, pp. 29–39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Ueland, J. Bollerslev, S. G. Wilson et al., “No associations between OPG gene polymorphisms or serum levels and measures of osteoporosis in elderly Australian women,” Bone, vol. 40, no. 1, pp. 175–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. S. S. Dong, X. Liu, Y. Chen et al., “Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians,” Calcified Tissue International, vol. 85, no. 2, pp. 104–112, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Vidal, M. Brincat, and A. X. Anastasi, “TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta,” Maturitas, vol. 53, no. 4, pp. 386–395, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Xu, X. X. Ma, L. W. Hu, L. P. Peng, F. M. Pan, and J. H. Xu, “Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis,” Clinical and Experimental Rheumatology, vol. 32, no. 5, pp. 697–704, 2014. View at Google Scholar
  28. G. Assmann, J. Koenig, M. Pfreundschuh et al., “Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study,” Journal of Rheumatology, vol. 37, no. 5, pp. 900–904, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. X. H. Ye, J. L. Cheng, and R. P. Liu, “Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis,” Genetics and Molecular Research, vol. 14, no. 2, pp. 6569–6577, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Guler, A. D. Turhanoglu, B. Ozer, C. Ozer, and A. Balci, “The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis,” Scandinavian Journal of Rheumatology, vol. 5, pp. 337–342, 2008. View at Google Scholar